Alvogen has an office in Bangkok, with a current team of five people. The team is led by Peter Keil, the EVP of Sales & Marketing in the APAC region. Current focus is on Portfolio Management and DRA activities to build up the necessary product range and infrastructure for further growth. Alvogen’s approach in Thailand is to continue registrations of new products and gradually build up product offering through partnerships and strategic portfolio acquisitions.
"The Thai pharmaceutical market is undergoing fundamental changes opening up opportunities for imported quality generics. However, tough regulatory hurdles (such as mandatory local BE studies and climate zone IV stability data) and strong local competition demand careful portfolio evaluation.
We plan to launch launch 25 products throughout the APAC region in 2012 and continue to strenghten our local team", says Peter Keil, EVP of Sales & Marketing in the APAC region (excluding China).